CD4 and prostate carcinoma: In a mouse model of prostate cancer (TRAMP C-2), the pharmacological inhibition of WHSC1 reduced the infiltration of CD4+CD25+ Tregs and upregulated MHC-II expression on CD45+CD11c+ DCs.